According to the business intelligence report titled ‘GLOBAL Intragastric Balloon Market 2019-2028’, available with Market Study Report, global intragastric balloon market is projected to expand at 12.33% CAGR between 2019-2028.
 

Rising obesity rate among people due to inactive lifestyle and unhealthy diets is fostering the demand for weight loss methods, boosting the growth of global intragastric balloon market. The non-invasive and quick nature of procedure, and short recovery time also facilitates the industry growth.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3552678/
 

While investments in research by government to reduce obesity will work in favor of business scenario, stomach ulcers as side-effect and temporary nature of treatment act as challenges for global intragastric balloon industry.
 

The report provides information about the industry share held by each segment in the past, while highlighting factors which facilitate the revenue inflow from these sectors. Besides, scrutiny of the latest developments is conducted to unveil lucrative opportunities in the market sphere.
 

Based on component, worldwide intragastric balloon market is bifurcated into single balloon, dual balloon, and triple balloon. Speaking of filling material, the industry is segregated into saline-filled, and gas-filled. Moving on to application spectrum, the market is divided into clinics, ambulatory surgical centers, and hospitals.
 

From the regional frame of reference, Asia Pacific intragastric balloon market is projected to record significant growth rate over the analysis period. Sedentary lifestyle coupled with unhealthy diet lead to obesity amongst the population, which further results in heart diseases, diabetes, stroke etc., hence augmenting the demand for weight loss procedures and impelling the market share.
 

Key players profiled in worldwide intragastric balloon industry report are Apollo Endosurgery Inc., ReShape Lifesciences Inc., Spatz FGIA Inc., Baronova Inc., Aspire Bariatrics Inc., Endalis, Obalon Therapeutics Inc., MEDSIL, Allurion Technologies, Silimed Inc., Districlass Medical SA, AbbVie Inc., and Helioscopie.
 

These industry behemoths are incorporating various strategies like collaborations & partnerships, and acquisitions & mergers, while investing in R&D activities to launch new products & technologies, hence gaining competitive edge and accumulating massive revenues.